Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Share News (CSRT)

  • There is currently no data for CSRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Consort Medical First Half Profit Falls Due To Cramlington Incident

Tue, 03rd Dec 2019 09:14

(Alliance News) - Consort Medical PLC on Tuesday said its interim profit was considerably smaller following an incident at its Aesica Cramlington manufacturing facility.

Consort's pretax profit for the six months ended October 31 was GBP1.2 million, far less than the GBP9.6 million profit posted the year before as revenue fell 4.3% to GBP146.0 million from GBP152.5 million.

This was primarily caused by the Cramlington incident, in which a small area of the Northumberland-based operating plant was damaged in what was described by Consort at the time as "the rapid thermal degradation of a chemical resulting in the expulsion of material and contamination of the facility".

This hurt the performance of its active pharmaceutical ingredients and finished dose manufacturing unit, Aesica, where revenue fell 11% to GBP81.1 million from GBP90.9 million.

Bespak, Consort's drug delivery devices unit, was unaffected, with revenue up 5.4% at GBP64.9 million versus GBP61.6 million the year prior.

On November 18, following the end of its first half, contract development and manufacturing pharmaceutical company Consort agreed to a GBP505 million bid from Swedish peer Recipharm AB. Recipharm will pay 1,010 pence in cash for each Consort share. The proposed deal implies an enterprise value of GBP627 million for Consort.

Given that Recipharm may reduce its acquisition consideration if any dividend or other distribution is made by the Hemel Hempstead-based company, Consort has opted not to declare an interim dividend.

Consort Chief Executive Jonathan Glenn said: "The board's expectations for the full year remain unchanged. We anticipate that the group's performance in the second half of the year will benefit from continued growth in Bespak, recommencing manufacture of the specific product involved in the Cramlington incident and a reduction in the backlog at Aesica.

"The group is subject to a recommended offer from Recipharm Holdings Ltd. The board remains confident of Consort's future prospects."

Shares in Consort were down 0.5% at 1,040.00 pence in London on Tuesday morning.

By Anna Farley; annafarley@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
1 Sep 2014 05:24

UK AGM, EGM Calendar - Week Ahead

Read more
29 Aug 2014 15:04

UK AGM, EGM Calendar - Week Ahead

Read more
29 Aug 2014 05:24

UK AGM, EGM Calendar - Week Ahead

Read more
28 Aug 2014 15:11

UK AGM, EGM Calendar - Week Ahead

Read more
18 Jul 2014 10:34

DIRECTOR DEALINGS: Consort Medical Non-Executive Buys Shares

Read more
19 Jun 2014 13:56

DIRECTOR DEALINGS: Consort Medical Executives Awarded, Sell Shares

Read more
18 Jun 2014 09:13

UK BROKER RATINGS: SocGen And HSBC Raise Whitbread Price Target

LONDON (Alliance News) - The following UK shares received analyst recommendations Wednesday morning:
----------
FTSE 100
----------
TRADERS: JEFFERIES INITIATES ROYAL MAIL WITH 'UNDERPERFORM' - TARGET 420 PENCE
----------
TRADERS: JEFFERIES RAISE

Read more
18 Jun 2014 09:03

Wednesday broker round-up UPDATE

Ashtead Group: Barclays ups target price from 930p to 946p retaining its overweight rating. Berkeley Group: Numis upgrades from hold to buy with a target price of 2491p. Brown (N) Group: Oriel places its buy recommendation under review. BT Group: Jefferies ups target price from 440p to 470p and k

Read more
17 Jun 2014 16:20

Consort Medical results meet expectations ahead of major launches

Inhaled drug delivery specialist Consort Medical produced a solid set of annual results as it completed a transitional year following a major disposal and ahead of two major product launches in the next two years. Consort, which sold its King Systems in February last year, lifted like-for-like rev

Read more
17 Jun 2014 08:36

Consort Medica Annual Profit Boosted By Chiesi NEXThaler Sales

LONDON (Alliance News) - Medical devices company Consort Medical PLC Tuesday reported higher profit and revenue for its recent financial year, which it said was boosted by strong growth in the sales of its Chiesi NEXThaler dry power inhaler for asthma sufferers. The designer and manufacture

Read more
17 Jun 2014 06:39

MARKET COMMENT: UK Stocks Set To Open Higher Ahead Of Inflation Data

LONDON (Alliance News) - UK stocks are set to open higher Tuesday ahead of UK Inflation data and eurozone economic sentiment readings to come. Global equity markets made a poor start to the week on Monday as investors exercised caution towards riskier assets amid the ongoing conflict in Ira

Read more
17 Jun 2014 05:26

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar 
Read more
16 Jun 2014 16:30

MARKET COMMENT: Geopolitics Weighs On FTSE But Miners Limit Downside

LONDON (Alliance News) - UK stock indices closed lower Monday as geopolitical concerns over both Iraq and Ukraine weighed on investor sentiment, while the mining stocks provided some support on the back of comments from Chinese Premier Li Keqiang.

Despite being lifted off intra-day

Read more
16 Jun 2014 15:17

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar 
Read more
16 Jun 2014 05:36

UK Earnings, Trading Statements Calendar - Week Ahead

Read more

Quickpicks are a member only feature

Login to your account